FDA Grants Priority Review For The Hepatitis C Drug "Sofosbuvir"
The U.S. Food and Drug Adminstration (FDA) has just granted priority review to Gilead Sciences Inc.’s latest New Drug Application
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓